RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer
imo, if BYD was "in the bag" and big pharma knew it, one of the big pharma cos wuld buy a large chunk in order to get to the technology. @ .23 cents and another flopped 460k pp I think that analysis is a stretch. Also, I biieve both the company and everyone on this board never even heard of "pre-btd application" as the company annoiunced the were applying for BTD back in nov 2022, and then again a few times in first half 2023. My take is, they applied, didn't do it right, had to go back to th drawing board and put together additional information. A year or so ago they hired Dr Vera something who this board praised as the one brought on to get btd, I believe several posters even said the only reason she left is because her "job was done" and she delivered BYD, just hadn't been announced yet. I agree, the. Umbers look great, but there is a disconnect between the science and efficacy of the treatment compared to management niliyybtp move this technology forward in regard to regulatory approvals. Those of us here 7+ years have seen this rom and time again